The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)

PHASE2UnknownINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 28, 2010

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

OT-551

OT-551 0.3% ophthalmic solution, 2 drops 4 times daily

DRUG

OT-551

OT-551 0.45% ophthalmic solution, 2 drops 4 times daily

DRUG

vehicle placebo

OT-551 0% ophthalmic solution, 2 drops 4 times daily

Trial Locations (17)

Unknown

Mesa

Tucson

Beverly Hills

Oxnard

Sacramento

Denver

Boynton Beach

Miami

Indianapolis

Novi

New York

Charlotte

Cleveland

Lakewood

Portland

Dallas

Houston

Sponsors
All Listed Sponsors
lead

Othera Pharmaceuticals

INDUSTRY